Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical
Glenmark Life Sciences Limited
-(GLS)
XNSE:GLS, XBOM:GLS
Glenmark Life Sciences Ltd Q3FY24; 56% fall in Profits
Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical
Glenmark Life Sciences Ltd Q2FY24; 11% rise in Profits
Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical
Glenmark Life Sciences Ltd Q1 FY24; 24% rise in Profits
Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical
Glenmark Life Sciences Limited (GLS) Q4 FY23 Earnings Concall Transcript
Glenmark Life Sciences Limited (NSE:GLS) Q4 FY23 Earnings Concall dated Apr. 28, 2023. Corporate Participants: Soumi Rao -- General Manager, Corporate Communications Yasir Rawjee -- Managing
Glenmark Life Sciences Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Glenmark Life Sciences Limited (GLS) Q3 FY23 Earnings Concall Q&A Highlights: [00:13:44] Tarang Agrawal of Old Bridge enquired about
Glenmark Life Sciences Limited Q2 FY23 Earnings Conference Call Insights
https://youtu.be/FHgUfHa30gw Key highlights from Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Management Update: [00:02:53] GLS said that the demand softness
Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Transcript
Glenmark Life Sciences Limited (NSE:GLS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Soumi Rao -- Head - Corporate Communications
Glenmark Life Sciences Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/02Igs_HUAfo Key highlights from Glenmark Life Sciences Limited (GLS) Q1 FY23 Earnings Concall Q&A Highlights: [00:14:56] Neha Manpuria from Bank of America
Glenmark Life Sciences Limited Q4 FY22 Earnings Conference Call Summary
https://youtu.be/au71QUL41tY Key highlights from Glenmark Life Sciences Limited (GLS) Q4 FY22 Earnings Concall Q&A Highlights: Neha Manpuria of Bank of America asked